Amylyx Pharmaceuticals: Avexitide define la reconstrucción endocrina (NASDAQ:AMLX)

· seekingalpha.com

Amylyx se orienta hacia el sector endocrino con avexitide en la Fase 3 LUCIDITY para la hipoglucemia posbariátrica; liquidez asegurada hasta 2028. Haga clic aquí para leer más.

Amylyx Pharmaceuticals ( AMLX ) is still frequently viewed through the lens of RELYVRIO (and ultimately the unsuccessful PHOENIX confirmatory trial) in ALS. How...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI